CONSOLIDATED STATEMENTS OF CASH FLOWS UNAUDITED (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income (loss)	$ 150,576	$ 40,264
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	42,385	(13,999)
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation expense	43,010	41,643
Amortization expense	57,419	57,884
Gains (Losses) on Extinguishment of Debt	8,419	55,652
Gain (Loss) on Disposition of Business	805	36,062
Gale settlement payment, net	(120,000)	0
Changes in assets and liabilities, net of effects from acquisition and divestiture of businesses:
Accounts receivable, net of provision for doubtful accounts	15,848	70,107
Inventories	17,807	(37,573)
Other current and noncurrent assets	(20,853)	5,897
Accounts payable	58,399	22,717
Accrued employee compensation	6,389	(17,196)
Current and noncurrent liabilities	94,350	194,528
Net cash flows from operating activities of continuing operations	354,554	455,986
Net cash flows from operating activities of discontinued operations	863	(1,321)
Net cash flows from operating activities	355,417	454,665
Cash flows from investing activities:
Acquisition of businesses, net of cash received	0	3,798
Proceeds from Divestiture of Businesses	71,194	11,083
Capital expenditures	(67,871)	(73,279)
Payments for (Proceeds from) Other Investing Activities	18	(441)
Net cash flows used in investing activities of continuing operations	3,305	(65,553)
Net cash flows used in investing activities of discontinued operations	(863)	(848)
Net cash flows used in investing activities	2,442	(66,401)
Cash flows from financing activities:
Payments on Term Loans	(15,938)	(15,938)
Payments on long-term borrowings and obligations	(176,983)	(190,403)
Payments of Debt Issuance Costs	0	4,851
Increase (decrease) in cash overdraft balance	(19,786)	(11,490)
Payments for Omnicare common stock repurchases	(160,438)	(91,259)
Proceeds for stock awards and exercise of stock options, net of stock tendered in payment	(293)	17,934
Dividends paid	(58,419)	(43,011)
Other	4,940	2,228
Net Cash Provided by (Used in) Financing Activities	(426,917)	(336,790)
Net increase (decrease) in cash and cash equivalents	(69,058)	51,474
Increase (decrease) in cash and cash equivalents of discontinued operations	0	(2,169)
Increase (decrease) in cash and cash equivalents of continuing operations	(69,058)	53,643
Cash and cash equivalents at beginning of period	356,001	444,620
Cash and cash equivalents at end of period	$ 286,943	$ 498,263